edaravone — United Healthcare
amyotrophic lateral sclerosis (ALS)
Initial criteria
- Diagnosis of amyotrophic lateral sclerosis (ALS)
Reauthorization criteria
- Documentation of positive clinical response to Radicava ORS therapy
Approval duration
12 months